基本信息
views: 3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Zhu has contributed significantly to the understanding of the cellular and mechanism underlying the pathogenesis of neurofibromatosis type 1 (NF1)-associated diseases, the role of tumor suppressor genes in normal development and brain tumorigenesis. Dr. Zhu has developed a series of genetically engineered mouse (GEM) models for a variety of NF1-associated diseases, including plexiform neurofibroma, malignant peripheral nerve sheath tumor (MPNST), low- and high-grade gliomas. Some or derivatives of these GEM models were used for the preclinical studies, serving the basis for the success of clinical trials using MEK inhibitors for plexiform neurofibroma. Further, Dr. Zhu’s group is one of the researcher groups that showed therapeutic efficacy of MEKi in treating NF1-associated diseases.
Research Interests
Papers共 210 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
INTERNATIONAL JOURNAL OF ORAL SCIENCEno. 1 (2024): 31-31
Journal of Magnesium and Alloysno. 3 (2024): 966-979
Cited0Views0Bibtex
0
0
Thomas U. Marron,Laura Brennan,Pauline Hamon,Maria Isabel Fiel, Stephen C. Ward,Yuan O. Zhu,Edward Kim,Alice O. Kamphorst,Pradeep Thanigaimani,Thomas S. Uldrick, Natalie Lucas, Kathy Wu,
CANCER RESEARCHno. 7 (2023)
ACS applied materials & interfacesno. 23 (2023): 27486-27501
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn